Consistent with this, ectopic PIM2 expression induced resistance to FLT3 inhibition in both FLT3-ITD–induced myeloproliferative neoplasm and AML models in mice [22], underscoring the role of PIMs in the emergence of this phenotype. The gene discussed is FLT3; the disease is myeloproliferative disorder.